Nicholas Pashos, PhD, joins Tulane School of Medicine as Entrepreneur in Residence

Nicholas Pashos, PhD, a seasoned expert in biomedical innovation and a veteran of the prestigious IndieBio accelerator program, has been named the first Entrepreneur in Residence at Tulane University School of Medicine.

Pashos, founder and CEO of the successful start-up company BioAesthetics, is well known for his scientific contributions in the fields of tissue engineering and regenerative medicine.  In addition, he is practiced in working with the FDA and navigating through clinical trials to bring his science into patients' lives.  His role at Tulane will leverage his real-world experiences as he advises the School of Medicine faculty, staff, and students who are passionately developing the next generation of medicine and biotechnology.  Working alongside Elaine Hamm, PhD, Tulane Medicine’s Executive in Residence, he will utilize his extensive background to help foster a culture of innovation and entrepreneurship within the school and amplify the pipeline of science feeding into the Business Development OfficeInnovation Institute, and Office of Intellectual Property Management.

"Dr. Nicholas Pashos' journey from scientist to entrepreneur brings important real-world experience - the good and the bad - that can only be learned by doing and experiencing it yourself.  His expertise in biomedical innovation, clinical trials, and successful entrepreneurship means he knows what it takes to bring technology from the academic realm to a company. He will reinforce Tulane Medicine's commitment to innovation and advancing healthcare," said Elaine Hamm, Executive in Residence. “He is a great addition to the team and expands our breadth and depth, layering his experience in device commercialization onto mine in drug development, allowing us to think of things from multiple angles.”

During his time with IndieBio, a renowned biotech accelerator, Pashos honed his skills in turning scientific concepts into viable business ventures. This experience, combined with his hands-on involvement in clinical trials, has given him a unique perspective on the challenges and opportunities of bringing medical innovations to market. 

“As a Tulane alumnus who did his research in a School of Medicine Laboratory, I’m excited to help other scientists and innovators avoid some of the inevitable obstacles and hurdles they could encounter as they seek to bring their ideas from the bench to the bedside,” said Pashos,  “The School of Medicine’s Business Development team was instrumental in introducing me to IndieBio, and as an entrepreneur in residence I look forward to making similar connections for the entire Tulane Medicine community.”

Pashos' appointment expands the external engagement efforts of the Tulane School of Medicine, which has been at the forefront of medical education and research since its founding in 1834.  His role is expected to significantly contribute to the school’s mission of advancing healthcare through cutting-edge research and innovation, ensuring Tulane Medicine’s spot as a top academic medical center in the Gulf South region.